Oncolytics Biotech (ONCY) News Today $1.07 +0.01 (+0.94%) Closing price 04:00 PM EasternExtended Trading$1.12 +0.04 (+4.21%) As of 07:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock ONCY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Cancer Treatment Revolution Drives $903B Market as New Therapies Gain MomentumAugust 28 at 10:39 AM | baystreet.caOncolytics Biotech® Announces Upcoming Investor Conferences in SeptemberAugust 28 at 8:30 AM | prnewswire.comHere's Why We're Watching Oncolytics Biotech's (NASDAQ:ONCY) Cash Burn SituationAugust 27 at 8:57 AM | finance.yahoo.comOncolytics Biotech Inc. (NASDAQ:ONCY) Receives Consensus Recommendation of "Moderate Buy" from AnalystsAugust 26 at 2:08 AM | marketbeat.comOncolytics Biotech Inc. (NASDAQ:ONCY) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAugust 24, 2025 | americanbankingnews.comOncolytics Biotech (NASDAQ:ONCY) Raised to Hold at Wall Street ZenAugust 17, 2025 | marketbeat.comLake Street Capital Begins Coverage on Oncolytics Biotech (NASDAQ:ONCY)August 15, 2025 | marketbeat.comLake Street Initiates Coverage of Oncolytics Biotech (ONCY) with Buy RecommendationAugust 14, 2025 | msn.comOncolytics Biotech Inc.: Oncolytics Biotech Announces Voting Results from the Annual General Meeting of ShareholdersAugust 12, 2025 | finanznachrichten.deOncolytics Biotech® Announces Voting Results from the Annual General Meeting of ShareholdersAugust 11, 2025 | prnewswire.comOncolytics Biotech (NASDAQ:ONCY) Issues Quarterly Earnings ResultsAugust 11, 2025 | marketbeat.comJonesTrading Remains a Hold on Oncolytics Biotech (ONCY)August 10, 2025 | theglobeandmail.comOncolytics Biotech Inc.: Oncolytics Biotech Reports Second Quarter Financial Results and Details Clinical Program Plans for PelareorepAugust 8, 2025 | finanznachrichten.deOncolytics Biotech Inc.: Oncolytics Biotech Announces Voluntary Delisting from the Toronto Stock ExchangeAugust 8, 2025 | finanznachrichten.deOncolytics Biotech Files SEC Report Incorporating Information CircularAugust 8, 2025 | tipranks.comOncolytics Biotech Reports Reduced Losses in Q2 2025 Financial UpdateAugust 8, 2025 | tipranks.comOncolytics Biotech® Reports Second Quarter Financial Results and Details Clinical Program Plans for PelareorepAugust 8, 2025 | prnewswire.comOncolytics Biotech® Announces Voluntary Delisting from the Toronto Stock ExchangeAugust 8, 2025 | prnewswire.comWhat to Expect from Oncolytics Biotech's EarningsAugust 7, 2025 | benzinga.comOncolytics Biotech® Announces Upcoming Annual General Meeting and Second Quarter Financial ResultsAugust 5, 2025 | prnewswire.comOncolytics Biotech (ONCY) Projected to Post Earnings on ThursdayJuly 31, 2025 | marketbeat.comOncolytics Biotech Inc. (NASDAQ:ONCY) Given Average Rating of "Moderate Buy" by BrokeragesJuly 30, 2025 | marketbeat.comOncolytics Biotech® to Engage FDA for Potential Registration-Enabled Study in First-Line Pancreatic Cancer with Goal to Launch Trial Activities by Year-EndJuly 29, 2025 | prnewswire.comOncolytics Biotech (NASDAQ:ONCY) Stock Price Up 3.8% - Time to Buy?July 29, 2025 | marketbeat.comCancer Surge Meets Funding Crunch as Breakthrough Biotechs Line Up Milestones in 2025July 24, 2025 | baystreet.caOncolytics Biotech Inc.: Oncolytics Biotech Regains Compliance with Nasdaq Trading RulesJuly 24, 2025 | finanznachrichten.deOncolytics Biotech Highlights Pelareorep’s Potential in Pancreatic Cancer at KOL EventJuly 23, 2025 | tipranks.comKey Opinion Leader Event Highlights Pelareorep's Compelling Pancreatic and Gastrointestinal Data And Future PotentialJuly 23, 2025 | prnewswire.comOncolytics Biotech Regains Nasdaq Compliance as of July 22, 2025July 22, 2025 | tipranks.comOncolytics Biotech® Regains Compliance with Nasdaq Trading RulesJuly 22, 2025 | prnewswire.comOncolytics Biotech® Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor TypesJuly 16, 2025 | prnewswire.comOncolytics Biotech Inc. (ONCY) - Yahoo Finance CanadaJuly 11, 2025 | ca.finance.yahoo.comUSA News Group: Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step UpJuly 10, 2025 | finanznachrichten.deOncolytics Biotech to Host Webinar on Pelareorep’s Potential in Cancer TreatmentJuly 10, 2025 | tipranks.comOncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal CancersJuly 10, 2025 | prnewswire.comOncolytics Biotech Highlights Promising Pelareorep Data in Cancer TreatmentJuly 10, 2025 | theglobeandmail.comGlobal Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies - The Globe and MailJuly 9, 2025 | theglobeandmail.comOncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling StudiesJuly 8, 2025 | prnewswire.comOncolytics Biotech Inc. (NASDAQ:ONCY) Given Average Recommendation of "Moderate Buy" by AnalystsJuly 5, 2025 | marketbeat.comOncolytics Biotech Inc. (NASDAQ:ONCY) Receives Average Rating of "Moderate Buy" from BrokeragesJuly 5, 2025 | marketbeat.comOncolytics Biotech (NASDAQ:ONCY) Trading Down 3% - Should You Sell?July 1, 2025 | marketbeat.comOncolytics Biotech® Appoints Former Ambrx Executive as Chief Business Officer to Drive Business Development StrategyJune 30, 2025 | prnewswire.comPrivate-Sector Oncology May Be the Market’s Best-Understood SecretJune 20, 2025 | baystreet.caUSA News Group: With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in OncologyJune 20, 2025 | finanznachrichten.deUSA News Group: Cancer Rates Are Surging in Young Adults -- Here's Where the Smart Money Is GoingJune 18, 2025 | finanznachrichten.deOncolytics Biotech® Names New CEO to Accelerate Momentum in Immunotherapy ProgramsJune 11, 2025 | prnewswire.comOncolytics Biotech® to Present New Clinical Trial Data at ASCO Showing Pelareorep's Unique Immune Activation CapabilitiesMay 23, 2025 | prnewswire.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Immunome (IMNM), Oncolytics Biotech (ONCY) and Hookipa Pharma (HOOK)May 18, 2025 | theglobeandmail.comJones Trading Downgrades Oncolytics Biotech (ONCY)May 17, 2025 | msn.comOncolytics Biotech Inc.: Oncolytics Biotech Reports First Quarter Financial Results and Highlights Clinical MomentumMay 17, 2025 | finanznachrichten.de Get Oncolytics Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for ONCY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ONCY Media Mentions By Week ONCY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONCY News Sentiment▼0.711.02▲Average Medical News Sentiment ONCY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONCY Articles This Week▼62▲ONCY Articles Average Week Get the Latest News and Ratings for ONCY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Oncolytics Biotech and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Aquestive Therapeutics News Today Olema Pharmaceuticals News Today Rocket Pharmaceuticals News Today Y-mAbs Therapeutics News Today Vigil Neuroscience News Today Astria Therapeutics News Today Fulcrum Therapeutics News Today Abeona Therapeutics News Today Inhibrx Biosciences News Today ADC Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONCY) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredThis strange black card is showing up across America"THIS is the Biggest Economic Story of 2025" While most Americans are focused on tariffs and inflation, the...Stansberry Research | SponsoredIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oncolytics Biotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncolytics Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access